Barclays Increases Kimberly-Clark (NYSE:KMB) Price Target to $144.00

Kimberly-Clark (NYSE:KMB) had its price target boosted by stock analysts at Barclays from $135.00 to $144.00 in a research note issued to investors on Friday, Benzinga reports. The firm currently has an “equal weight” rating on the stock. Barclays‘s price target suggests a potential upside of 1.54% from the stock’s current price.

A number of other equities research analysts have also issued reports on the stock. StockNews.com lowered shares of Kimberly-Clark from a “strong-buy” rating to a “buy” rating in a report on Tuesday, July 30th. Bank of America raised shares of Kimberly-Clark from an “underperform” rating to a “buy” rating and increased their price objective for the company from $115.00 to $160.00 in a report on Thursday, June 13th. Piper Sandler increased their price objective on shares of Kimberly-Clark from $167.00 to $174.00 and gave the company an “overweight” rating in a report on Thursday, July 11th. Deutsche Bank Aktiengesellschaft increased their price objective on shares of Kimberly-Clark from $146.00 to $147.00 and gave the company a “hold” rating in a report on Tuesday. Finally, BNP Paribas started coverage on shares of Kimberly-Clark in a report on Monday, June 24th. They set a “neutral” rating and a $146.00 price objective for the company. Two investment analysts have rated the stock with a sell rating, eight have given a hold rating and seven have assigned a buy rating to the company’s stock. According to MarketBeat, the company presently has an average rating of “Hold” and an average price target of $147.07.

Kimberly-Clark Stock Performance

NYSE KMB traded up $0.76 on Friday, reaching $141.82. 264,711 shares of the stock were exchanged, compared to its average volume of 2,096,042. Kimberly-Clark has a one year low of $116.63 and a one year high of $149.30. The firm has a market capitalization of $47.76 billion, a PE ratio of 21.01, a PEG ratio of 2.98 and a beta of 0.39. The company’s 50-day simple moving average is $142.55 and its two-hundred day simple moving average is $137.59. The company has a current ratio of 0.85, a quick ratio of 0.58 and a debt-to-equity ratio of 5.59.

Kimberly-Clark (NYSE:KMB) last released its earnings results on Tuesday, July 23rd. The company reported $1.96 EPS for the quarter, topping analysts’ consensus estimates of $1.71 by $0.25. Kimberly-Clark had a net margin of 11.28% and a return on equity of 223.55%. The company had revenue of $5.03 billion for the quarter, compared to analysts’ expectations of $5.10 billion. During the same quarter last year, the business earned $1.65 EPS. The firm’s revenue was down 2.0% compared to the same quarter last year. Analysts expect that Kimberly-Clark will post 7.25 EPS for the current fiscal year.

Insider Transactions at Kimberly-Clark

In other news, insider Gonzalo Uribe sold 1,780 shares of Kimberly-Clark stock in a transaction on Monday, July 29th. The stock was sold at an average price of $140.84, for a total transaction of $250,695.20. Following the completion of the sale, the insider now directly owns 7,377 shares in the company, valued at approximately $1,038,976.68. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. In other news, insider Gonzalo Uribe sold 1,780 shares of Kimberly-Clark stock in a transaction on Monday, July 29th. The stock was sold at an average price of $140.84, for a total transaction of $250,695.20. Following the completion of the sale, the insider now directly owns 7,377 shares in the company, valued at approximately $1,038,976.68. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Jeffrey P. Melucci sold 37,699 shares of Kimberly-Clark stock in a transaction dated Thursday, July 25th. The shares were sold at an average price of $141.42, for a total value of $5,331,392.58. Following the completion of the sale, the insider now owns 19,935 shares of the company’s stock, valued at $2,819,207.70. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 0.62% of the company’s stock.

Institutional Trading of Kimberly-Clark

Several institutional investors and hedge funds have recently made changes to their positions in KMB. Price T Rowe Associates Inc. MD raised its holdings in shares of Kimberly-Clark by 19.1% in the first quarter. Price T Rowe Associates Inc. MD now owns 5,893,146 shares of the company’s stock valued at $762,279,000 after acquiring an additional 944,920 shares in the last quarter. Wulff Hansen & CO. grew its stake in Kimberly-Clark by 13,720.0% in the second quarter. Wulff Hansen & CO. now owns 641,524 shares of the company’s stock valued at $88,659,000 after purchasing an additional 636,882 shares during the last quarter. Marshall Wace LLP grew its stake in Kimberly-Clark by 48.4% in the second quarter. Marshall Wace LLP now owns 1,545,147 shares of the company’s stock valued at $213,539,000 after purchasing an additional 503,839 shares during the last quarter. Dimensional Fund Advisors LP grew its stake in Kimberly-Clark by 22.4% in the second quarter. Dimensional Fund Advisors LP now owns 1,934,655 shares of the company’s stock valued at $267,383,000 after purchasing an additional 354,501 shares during the last quarter. Finally, Capital World Investors grew its stake in Kimberly-Clark by 17.8% in the first quarter. Capital World Investors now owns 2,269,492 shares of the company’s stock valued at $293,559,000 after purchasing an additional 342,790 shares during the last quarter. 76.29% of the stock is currently owned by institutional investors.

About Kimberly-Clark

Kimberly-Clark Corporation, together with its subsidiaries, manufactures and markets personal care and consumer tissue products in the United States. It operates through three segments: Personal Care, Consumer Tissue, and K-C Professional. The company’s Personal Care segment offers disposable diapers, training and youth pants, swimpants, baby wipes, feminine and incontinence care products, reusable underwear, and other related products under the Huggies, Pull-Ups, Little Swimmers, GoodNites, DryNites, Sweety, Kotex, U by Kotex, Intimus, Thinx, Poise, Depend, Plenitud, Softex, and other brand names.